A Nomogram Based on the Castelli Risk Index for Predicting Prognosis in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Cohort Study
Immunity, Inflammation and Disease · 2026-04 · 14 (4)
DOI: 10.1002/iid3.70431 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 07.04.2026. Verfasst von Yan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Nomograms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Provincial Department of Education Graduate Innovation Funding Project.
Abstract (Originalsprache)
Background and Aims Composite lipid indices are closely related to the risk and poor prognosis of diseases. However, there are no studies on the prognostic value of Castelli's risk indices‐I and II (CRI‐I, CRI‐II) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Therefore, the aim of this study was to investigate the association of CRI‐I and CRI‐II with the prognosis of patients with ACS undergoing PCI. Patients and Methods A total of 1475 patients with ACS undergoing PCI were consecutively enrolled in this prospective cohort study from January 2016 to December 2018. The CRI‐I and CRI‐II were measured. The endpoints were MACEs, including all‐cause mortality, requirement of rehospitalization for severe heart failure, recurrence of myocardial infarction, in‐stent restenosis, and reaccept PCI. Follow‐up data were collected via clinical visits or telephone calls at 1, 3, 6, and 12 months and annually thereafter.
Result
Multivariable Cox regression analysis revealed that the risk of MACEs increased gradually with increasing CRI‐I and CRI‐II. The cumulative survival rate in the CRI‐I ≥ 3.350 and CRI‐II ≥ 1.697 groups was significantly lower than that in the CRI‐I < 3.350 and CRI‐II < 1.697 groups, respectively (log‐rank tests: all p < 0.001). The nomogram demonstrated good predictive performance for the 1‐, 2‐, and 3‐year survival probability.
Conclusions
CRI‐I ≥ 3.350 and CRI‐II ≥ 1.697 could serve as independent predictors of MACEs in patients with ACS undergoing PCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
- The Cardiovascular Research Institute of Chengde, Chengde, China.
- Hebei Key Laboratory of Panvascular Diseases, Chengde, China.
- Central Laboratory of Chengde Medical University Affiliated Hospital, Chengde, China.
ORCID-Profile: Yan Liu, Ge Song, Ying Zhang, Weichao Shan, Yuewen Qi, Xinchen Wang, Chen Wei, Jingyi Liu, Lixian Sun
Förderung
- Hebei Provincial Department of Education Graduate Innovation Funding Project
Zitieren
APA
Liu, Y., Song, G., Zhang, Y., Shan, W., Qi, Y., Wang, X., Chen Wei, Liu, J., & Sun, L. (2026). A Nomogram Based on the Castelli Risk Index for Predicting Prognosis in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Cohort Study. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70431
Vancouver
Liu Y, Song G, Zhang Y, Shan W, Qi Y, Wang X, et al. A Nomogram Based on the Castelli Risk Index for Predicting Prognosis in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Cohort Study. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70431
BibTeX
@article{Liu2026,
author = {Liu, Yan and Song, Ge and Zhang, Ying and Shan, Weichao and Qi, Yuewen and Wang, Xinchen and Chen Wei and Liu, Jingyi and Sun, Lixian},
title = {A Nomogram Based on the Castelli Risk Index for Predicting Prognosis in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Cohort Study},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/iid3.70431}
}
EUVIMED